Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Gallium scanning in Paget's disease of bone: effect of calcitonin

Journal Article · · Am. J. Roentgenol.; (United States)
 [1]; ; ;
  1. Cedars-Sinai Medical Center, Los Angeles, CA

Calcitonin has been used in the treatment of Paget's disease of bone, and serum alkaline phosphatase level and 24 hr urinary hydroxyproline excretion have been used to follow therapeutic response. The radionuclide bone scan has been used as a visual indicator; however, there is some uncertainty as to its value in following changes in disease activity. Four patients with both serial technetium phosphate bone scans and serial gallium studies were studied. In each case the beneficial effect of calcitonin was demonstrated more accurately with gallium than with technetium diphosphonate. Since biochemical changes in Paget's disease are believed to be mediated at the cellular level and gallium uptake depends on cellular activity, it is proposed that gallium uptake is more appropriate measure of the activity of Paget's disease than a noncellular marker such as a technetium-containing bone scan agent.

OSTI ID:
5371869
Journal Information:
Am. J. Roentgenol.; (United States), Journal Name: Am. J. Roentgenol.; (United States) Vol. 134:2; ISSN AJROA
Country of Publication:
United States
Language:
English

Similar Records

Skeletal distribution and biochemical parameters of Paget's disease
Journal Article · Tue Mar 31 23:00:00 EST 1987 · Clin. Orthop. Relat. Res.; (United States) · OSTI ID:6617384

Gallium-67 citrate localization in osteoclast nuclei of Paget's disease of bone
Journal Article · Wed Jun 01 00:00:00 EDT 1988 · J. Nucl. Med.; (United States) · OSTI ID:6973683

Evaluation of /sup 99m/Tc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment
Conference · Wed Nov 30 23:00:00 EST 1977 · Radiology; (United States) · OSTI ID:5335170